RVXCF
Price:
$0.1
Market Cap:
$24.87M
Resverlogix Corp., a late-stage clinical biotechnology company, develops therapeutics for disease states with high unmet medical needs. It is developing apabetalone (RVX-208), a small molecule selective bromodomain and extra-terminal inhibitor that is in Phase III clinical trial for patients with cardiovascular disease, diabetes mellitus, chronic kidney disease, end-stage renal disease, and neurodegenerative diseases. Resverlogix Corp. has a partnership with Eversana Life Science Services, LLC to support the pending launch of the commercialization of apabetalone for Covid-19 in the United States and Canada. The company is headquartered in Calgary, Canada.
Industry
Biotechnology
IPO Date
2009-02-13
Stock Exchange
OTC
Ticker
RVXCF
According to Resverlogix Corp.’s latest financial reports and current stock price. The company's current PE Ratio is -3.33. This represents a change of -98.98% compared to the average of -327.06 of the last 4 quarters.
The mean historical PE Ratio of Resverlogix Corp. over the last ten years is 6.42K. The current -3.33 PE Ratio has changed -105.19% with respect to the historical average. Over the past ten years (40 quarters), RVXCF's PE Ratio was at its highest in in the March 2021 quarter at 2.01K. The PE Ratio was at its lowest in in the March 2023 quarter at -1314.66.
Average
6.42K
Median
-2.84
Minimum
-3726.06
Maximum
67.93K
Discovering the peaks and valleys of Resverlogix Corp. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 6.47%
Maximum Annual PE Ratio = 67.93K
Minimum Annual Increase = -1243.07%
Minimum Annual PE Ratio = -3726.06
| Year | PE Ratio | Change |
|---|---|---|
| 2022 | -7.28 | 86.42% |
| 2021 | -3.90 | -100.01% |
| 2020 | 67.93K | 6.47% |
| 2020 | 1.05 | -100.03% |
| 2019 | -3726.06 | 156.93% |
| 2018 | -2.37 | -28.29% |
| 2017 | -3.31 | -44.09% |
| 2016 | -5.92 | -158.73% |
| 2015 | 10.08 | -1243.07% |
| 2014 | -0.88 | -115.39% |
The current PE Ratio of Resverlogix Corp. (RVXCF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
22.64K
5-year avg
12.84K
10-year avg
6.42K
Resverlogix Corp.’s PE Ratio is less than Finch Therapeutics Group, Inc. (-1.64), greater than Bonus BioGroup Ltd. (-6.85), greater than Starpharma Holdings Limited (-16.54), greater than Institute of Biomedical Research Corp. (-25.26), less than Celyad Oncology S.A. (-1.18), greater than Evolva Holding S.A. (-6.64), less than MediPharm Labs Corp. (-3.00), less than Zenith Capital Corp. (-1.47), less than Charlotte's Web Holdings, Inc. (-0.82), greater than Cell Source, Inc. (-4.90),
| Company | PE Ratio | Market cap |
|---|---|---|
| -1.64 | $22.80M | |
| -6.85 | $93.43M | |
| -16.54 | $87.83M | |
| -25.26 | $16.23M | |
| -1.18 | $8.06M | |
| -6.64 | $7.93M | |
| -3.00 | $19.72M | |
| -1.47 | $11.15M | |
| -0.82 | $17.75M | |
| -4.90 | $17.11M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Resverlogix Corp. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Resverlogix Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Resverlogix Corp.'s PE Ratio?
How is the PE Ratio calculated for Resverlogix Corp. (RVXCF)?
What is the highest PE Ratio for Resverlogix Corp. (RVXCF)?
What is the 3-year average PE Ratio for Resverlogix Corp. (RVXCF)?
What is the 5-year average PE Ratio for Resverlogix Corp. (RVXCF)?
How does the current PE Ratio for Resverlogix Corp. (RVXCF) compare to its historical average?